AMED: Amedisys, Inc. Stock

SIC 8082 – Home Health Care Services

Valuation
Market Cap ($M) 3,020.45
Enterprise Value ($M) 3,345.44
Book Value ($M) 1,119.78
Book Value / Share 34.28
Price / Book 2.70
NCAV ($M) -443.45
NCAV / Share -13.57
Price / NCAV -6.81

Profitability (mra)
Return on Invested Capital (ROIC) -0.01
Return on Assets (ROA) -0.00
Return on Equity (ROE) -0.01

Liquidity (mrq)
Quick Ratio 1.05
Current Ratio 1.05

Balance Sheet (mrq) ($M)
Current Assets 496.94
Assets 2,060.17
Liabilities 940.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,236.38
Operating Income 193.66
Net Income -9.75
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 137.19
Cash from Investing 35.06
Cash from Financing -87.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 9.86 2.88
02-12 13G/A Flynn James E 0.00 -100.00
02-08 13G/A Wellington Management Group Llp 0.00 -100.00
01-24 13G/A BlackRock Inc. 9.10 -27.81
07-06 13G/A Jpmorgan Chase & Co 2.30 -56.09

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-10-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION RE
2023-07-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 28,448 246,392 11.55
2024-03-27 34,087 139,279 24.47
2024-03-26 91,695 340,847 26.90
2024-03-25 101,107 360,040 28.08

(click for more detail)

Similar Companies
ADUS – Addus HomeCare Corporation AVAH – Aveanna Healthcare Holdings Inc.
BTSG – BrightSpring Health Services, Inc. OPCH – Option Care Health, Inc.


Financial data and stock pages provided by
Fintel.io